Drugs / Latanoprost bunod
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03949244 | Aug 2019 → Oct 2020 | open-angle glaucoma | Icahn School of Medicine at Mount Sinai | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Latanoprost bunod | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03949244 ↗ |
| Route | Topical | “topically-applied latanoprostene bunod (LTB)” NCT03949244 ↗ |